{"product_id":"fda-483-nov-2024-bausch-health-us-llc-dexcom-inc-boston-scientific-corporation","title":"FDA 483 – Nov 2024: Bausch Health US., LLC; Dexcom, Inc.; Boston Scientific Corporation","description":"\u003cb\u003eRequest Contents:\u003c\/b\u003e Form 483 Requests: Inspection reports from November 2024 for:\nBausch Health US., LLC, 400 Somerset Corporate Blvd, Bridgewater, NJ, 08807-2867, United States\nDexcom, Inc., 6340 Sequence Dr, San Diego, CA, 92121-4356, United States\nBoston Scientific Corporation, 100 Boston Scientific Way, Marlborough, MA, 01752-1234, United States","brand":"FDA","offers":[{"title":"Default Title","offer_id":50791085539492,"sku":"FDAFT318","price":89.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/foiadocs.com\/products\/fda-483-nov-2024-bausch-health-us-llc-dexcom-inc-boston-scientific-corporation","provider":"FOIA Document Source","version":"1.0","type":"link"}